CRIPS and Prof John Beltrame AM/CEO Innovation Award
Learn more about this award and how it can benefit patients while developing innovative solutions.
NEED TO SORT OUT ANCHOR LINKING FROM WITHIN ACCORDIONS TO CONTACT CTA BOX ON BOTTOM OF PAGE, ASSETS & INDIVIDUAL EMAILS. Check every link within every accordion.
checkViewport(), 100)"> About the grant
The CALHN CEO Clinical Rapid Implementation Project Scheme (CALHN CEO CRIPS Grant) provides funding support for novel projects that will improve health service delivery within CALHN.
CRIPS offers grants of up to $200,000 over two years to support innovative projects that identify real solutions and improve health service delivery within CALHN.
It is anticipated that the successful projects could be implemented as a CALHN policy within 12 months of completion of the 2-year grant, while generating ideas for future federal grant applications - such as the Medical Research Future Fund (MRFF).
The Prof John Beltrame AM / CEO Innovation Award is an additional award from the same pool of applicants, selected on the basis of developing innovative solutions to address unmet needs.
These grants are supported by donations held by the Health Services Charitable Gift Board (HSCGB) and projects need to benefit patients and/or improve health service delivery at CALHN.
Expressions of interest
The 2025-27 Expressions of Interest are now closed.
We expect the 2026-28 process to commence in May/June 2025.
checkViewport(), 100)"> Selection process
The following information needs to be provided.
- Investigator information
- Project details (250 words)
- Title
- Primary study question
- Primary study implementation outcome measured
- Lay description
- Benefit to CALHN patients
- Digital or data recording component (yes/no)
A shortlist of applications will be selected by an external panel and invited to submit a full application.
Applications for CALHN CEO CRIPS Grants will be a two-step process.
1. Expression of interest
This initial application step will include the clinical research team details and a project synopsis, which will be evaluated by an external assessment panel.
Submit an expression of interest form.
2. Invited full application
Top ranked expressions of interest will be invited to submit a full application.
Full applications will be evaluated by the CALHN executive expert panel (i.e. CALHN governing and executive board, or other personnel at the discretion of the CALHN CEO) and may be requested to attend an interview.
Up to four (4) grants will be awarded.
Scores/rankings will not be disclosed to applicants. The review panel’s decision is final, and no further correspondence will be considered.
Timeline
Stage
Date
Expression of interest - open
Friday 10 May 2024
Expression of interest - closed
Monday 3 June 2024, 11:30pm. This deadline is final - no additional extensions accepted.
Notifications of EOI outcomes and invitation for full applications
1 August 2024
Invited finalist full applications - closed
Monday 20 August, 1:00pm
Grant award notification
CALHN research week - 14-18 October, 2024
These criteria include:
- Chief Investigator-A (CI-A, Principal Investigator) must be a member of the CALHN clinical staff working at CALHN sites:
- Royal Adelaide Hospital
- The Queen Elizabeth Hospital
- Hampstead Rehabilitation Hospital
- Mental health services at Glenside Health Service.
- Statewide Rehabilitation Services at the Repat Health Precinct
- Up to 3 additional chief investigators (CI-B, C or D) may be included in the application but a staff member may only be listed as CI-A on one application.
Note: We encourage diversity and inclusivity regarding Chief Investigators. - Current CRIPS grant recipient chief investigators cannot be the CI-A for this application round but may fulfil the role of CI-B, C or D on other applications.
- The project must be primarily based within CALHN but collaboration with other institutions/networks is strongly encouraged.
- If funding is being sought to support the employment of the CIA, this must be at CALHN and not an external Institution.
After expressions of interest are screened for eligibility, the following scoring matrix will be used by external assessors to score each application.
Assessors will not assess an application if there is a direct conflict of interest.
*Study relevance - why is the study?
*Feasibility - How it will be achieved?
*Impact on patient care - the 'so what' expected outcomes/impact
Score
Study relevance*
Feasibility*
Impact on patient care*
5
Essential healthcare study
Team will achieve
Major change in patient care
4
Very important study
Very achievable
Important change in care
3
Probably important study
Probably achievable
Probable change in care
2
Possibly important study
Possibly achievable
Possible change in care
1
Unimportant to healthcare
Poor methodology
Unlikely change practice
0
Not adequately addressed
Not adequately addressed
Not adequately addressed
- Each grant award is a maximum of $200,000 (GST inclusive) over two years (i.e. $100,000 per financial year).
- Successful awards announced during CALHN Research Week in the same year of application.
- Note: ethics/governance requirements must be approved by July 2025.
Funds will only be available from 1 July 2025 (up to $15,000 may be pre-released prior to July, to support staff preparing ethics/governance submissions).
The following will be managed by CALHN research services:
- collaboration and/or service agreements
- financial statements – due 31 July 2026 and 2027
- reporting - all reports should be submitted to CALHN Research Grants on the reporting template provided to grant recipients
- progress reports - due 6 monthly
- 31 Jan 2026
- 31 Jul 2026
- 31 Jan 2027
- progress reports - due 6 monthly
- final report - due 30 September 2026
- progress reports to document continued compliance with eligibility criteria
- CIs to notify CALHN Communication and Engagement team regarding promotional opportunities by visiting the CALHN intranet website
- Acknowledgement of funding support from the RAH Research Fund must be included in any presentation/paper arising from the research. Use the following acknowledgement:
- funding for the study was provided by a competitive research grant from the Clinical Rapid Implementation Project Scheme of CALHN, funded by the RAH Research Fund administered by the Health Services Charitable Gifts Board (HSCGB)
- Project grant may be terminated if above criteria are not fulfilled.
checkViewport(), 100)"> Contact us
Internal grants
Health Services Charitable Gifts Board (HSCGB)
Scholarships
Fellowships
Grants and awards
This page was last updated 9 May 2025.